More MS news articles for Mar 2002

A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11886356&dopt=Abstract

Acta Neurol Scand 2002 Mar;105(3):152-7
Fierro B, Salemi G, Brighina F, Buffa D, Conte S, Bua VL, Piazza A, Savettieri G.
Institute of Neuropsichiatry, University of Palermo, Palermo, Italy.

Objective

To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses.

Background

Transcranial Magnetic Stimulation (TMS) is the most sensitive neurophysiological ascertainment to quantify motor disability, to follow the recovery from an MS relapse, and to detect the response to treatment.

Design and method

Twenty-four clinically definite relapsing -- remitting MS patients presenting a relapse were randomly assigned to a treatment for 5 days with IVMP 1 or 2 g/day. The response to treatment of each patient was evaluated through Expanded Disability Status Scale (EDSS), Medical Research Council (MRC) score, and TMS by means of motor evoked potential (MEP) parameters.

Results

Motor threshold (MT), central motor conduction time (CMCT) and MRC showed a higher improvement with the highest dose of IVMP. Silent period and EDSS improved with both treatments.

Conclusion

The dose of 2 g/day of IVMP is more effective in MS relapse.